TipRanks
Go Ultimate55% OFF

John E. Bishop Insider Profile

11 Followers

John E. Bishop, Chief Technical and Quality Officer at Ardelyx, holds 317.10K shares in Ardelyx (Ticker: ARDX), holds 0.00 shares in Forma Therapeutics Holdings (Ticker: FMTX), holds 93.52K shares in Momenta Pharma (Ticker: MNTA). Most recently, John E. Bishop Sold ― shares of Ardelyx on Aug 25, 2026 for an estimated value of $76.04K.

John E. Bishop's Trading History

ARDX
Ardelyx
Aug 25, 2026Chief Technical and Quality OfficerInformative Sell76.04K$960.80K
FMTX
Forma Therapeutics Holdings
Oct 14, 2022―Uninformative Sell―$0.00
MNTA
Momenta Pharma
May 23, 2016―Uninformative Sell8.00K$4.91M
LYRA
Lyra Therapeutics
―CTO――

You May Also Like

John E. Bishop insider profile FAQ

What is the percentage of profitable transactions made by John E. Bishop?
The percentage of profitable transactions made by John E. Bishop is 100%.
What is the average return per transaction made by John E. Bishop?
The average return per transaction made by John E. Bishop is 39.10%.
What stocks does John E. Bishop hold?
John E. Bishop holds: ARDX, MNTA, LYRA, FMTX stocks.
What was John E. Bishop’s latest transaction?
John E. Bishop’s latest transaction was an Informative Sell of $76.04K.
What was John E. Bishop's most profitable transaction?
John E. Bishop’s most profitable transaction was an Informative Sell of ARDX stock on May 22, 2026. The return on the trade was 50.40%.
What is John E. Bishop's role in Ardelyx?
John E. Bishop's role in Ardelyx is Chief Technical and Quality Officer.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.

TipRanks measures corporate insiders by the stock transactions they report to the SEC. See how TipRanks ranks experts and calculates performance.